JB Try AEM Online
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergthorsson, U.
Right arrow Articles by Roth, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergthorsson, U.
Right arrow Articles by Roth, J. R.
Journal of Bacteriology, January 2005, p. 400-403, Vol. 187, No. 1
0021-9193/05/$08.00+0     doi:10.1128/JB.187.1.400-403.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Natural Isolates of Salmonella enterica Serovar Dublin Carry a Single nadA Missense Mutation

Ulfar Bergthorsson{dagger} and John R. Roth*

Department of Biology, University of Utah, Salt Lake City, Utah

Received 1 August 2004/ Accepted 28 September 2004


    ABSTRACT
 Top
 Abstract
 Text
 References
 
Nicotinic acid is required by most isolates of Salmonella enterica (serovar Dublin), a pathogen of cattle. A single nadA missense mutation causes the nutritional requirement of all serovar Dublin isolates tested. Models for persistence of this allele are tested and discussed.


    TEXT
 Top
 Abstract
 Text
 References
 
While most natural isolates of Salmonella enterica and Escherichia coli grow on minimal medium, a small percentage are auxotrophs, many with a defect in pyridine (NAD) synthesis (1, 29, 36, 42). Pyridine auxotrophy (3, 11) is characteristic of particular bacterial subgroups including the cattle pathogen S. enterica (serovar Dublin) (7, 10) and Shigella spp. (3, 43). Persistent auxotrophy may reflect important aspects of bacterial life history and population structure. The following explanations are tested here.

(i) Relaxed selection for prototrophy. Natural conditions might provide nutrients and allow particular auxotrophic mutations to escape purifying selection and drift to high frequency. This seems particularly likely for nutrients required at low levels.

(ii) Conditional auxotrophy. The auxotrophy seen in the laboratory might be corrected under frequently encountered natural conditions. Many laboratory mutants are corrected by low temperature or high salt (19), as are some naturally occurring pyridine auxotrophs of E. coli (1, 21, 46).

(iii) Selection for auxotrophy. An auxotrophic mutant allele could be selectively maintained if it provided a fitness advantage under some conditions. Resistance to some antibiotics can result from reduced proton motive force (PMF), which is required for their import. Starvation of a nad auxotroph might reduce PMF by limiting NAD levels and compromising electron transport. A precedent is streptomycin resistance (Strr) seen under anaerobic conditions (38) or when respiration is compromised by impaired heme synthesis (37). Mutations (strB = isc) cause Strr by reducing PMF by their failure to repair oxidized iron-sulfur clusters (40). A leaky nadD mutation causes resistance to fusidic acid and trimethoprim (41).

(iv) Mutation pressure. Mutator alleles are found in 1 to 2% of natural isolates of E. coli and S. enterica and might generate auxotrophic mutations faster than selection can remove them (23). Furthermore, some genes contain sequence motifs that are local mutational hot spots at which the same mutation is generated repeatedly (2, 8, 14, 27).

These possibilities were tested for pyridine-requiring strains of the cattle pathogen, S. enterica serovar Dublin. Analysis was facilitated because serovar Dublin strains can be transductionally crossed with characterized pyridine (nad) auxotrophs of serovar Typhimurium (33).

Auxotrophy of serovar Dublin isolates. The auxotrophy of serovar Dublin is satisfied by extremely low levels (<1µM) of nicotinic acid or nicotinamide and by the intermediate quinolinic acid, suggesting a deficiency in one of the first two steps in the pathway, nadA or nadB. Serovar Dublin strains tested were TR6325, obtained from J. Farmer at Centers for Disease Control and Prevention (Atlanta, Ga.), and strains TR7209 to -12 (SL1 to -4) from Steven Libby, University of Washington (24). Strains from the Salmonella reference collection B (SARB) collection (6) were SARB12, the most common serovar Dublin type based on multilocus enzyme electrophoresis (39), SARB13 (requiring thiamine in addition to a pyridine), and SARB14 (the only serovar Dublin isolate tested that did not require a pyridine compound).

Reversion tests. Auxotrophic serovar Dublin strains revert to growth on minimal glucose. By a fluctuation test (25), serovar Dublin isolate TR7209 was found to revert at a rate of 10–10/cell/division, a rate typical for alterations of a particular base pair (15). Mutation rate was estimated as –ln(P0)/n, where n is the number of cells in a culture and P0 is the fraction of 26 (1-ml) cultures with zero mutations (scored on day 3).

Initial evidence for a nadA mutation. Serovar Dublin strains TR7209, TR7211, and SARB13 were transduced to prototrophy using phage P22 grown on nadA, -B, or -C insertion mutants (Tn10) of serovar Typhimurium. Only the nadA mutant donor showed reduced ability to repair the Na requirement. This suggested that serovar Dublin's defect is in the nadA gene and repair efficiency is reduced because it requires an exchange between the donor and recipient nad mutations.

The serovar Dublin nadA allele is necessary and sufficient for auxotrophy. To verify the serovar Dublin nadA mutation, a nonauxotrophic pnuC::MudJ(Knr) insertion closely linked to nadA in serovar Typhimurium was transduced into several serovar Dublin isolates (SARB13, TR7209, and TR7212) selecting kanamycin resistance. Of Knr recombinants, 83% lost their pyridine requirement, showing linkage of the serovar Dublin mutation to the nadA region. A Knr serovar Dublin transductant that retained its pyridine requirement was used as donor with wild-type serovar Typhimurium. Among the serovar Typhimurium transductants inheriting pnuC::MudJ(Knr), 90% inherited auxotrophy from serovar Dublin. An analogous set of crosses using a nadA-linked Tn10dTc insertion (zbh-3652::Tn10dTc) produced similar results. Thus, a mutation in or near the nadA gene is both necessary and sufficient for serovar Dublin's nutritional requirement.

Comparing nadA sequences of enteric bacteria. The nadA genes of several serovar Dublin strains and derived Nad+ revertants were compared to those of serovars Typhimurium and Typhi (9, 13, 28, 32). As seen in Table 1, a valine residue at position 111 (codon GTG) correlates with pyridine auxotrophy (boxed columns). An alanine residue (codon GCG) is found at this position in prototrophic strains (serovar Typhimurium and the one prototrophic serovar Dublin isolate SARB14). Furthermore, prototrophic revertants of serovar Dublin strain TR7209 (strains TR7275 and TR7276) replace the valine of parental serovar Dublin with the alanine seen in prototrophic isolates. Thus, alanine 111 appears essential for NadA activity and valine at this position causes the auxotrophy of serovar Dublin isolates.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Polymorphic sites in nadA of serovar Typhimurium, Typhi, and Dublin isolates

 
Like prototrophic Salmonella strains, E. coli has alanine at this site (5, 12, 34, 45). However, valine is found there in Shigella flexneri 2a (17, 44), consistent with the pyridine requirement of most Shigella isolates. This may not conflict with a report that S. flexneri is defective in nadB, not nadA (26), because Shigella lineages have evolved several times from E. coli (35) and thus may carry different mutations.

Differences between serovars Typhi and Typhimurium are distributed across the entire nadA gene. However, the 5' half of the serovar Dublin sequence resembles that of serovar Typhi, while the 3' half resembles that of serovar Typhimurium (Table 1). A portion of the 3' half of serovar Typhi is more similar to E. coli and Shigella than to other salmonellae (data not shown). This suggests multiple recombination events within the nadA loci of enteric bacteria.

A search for conditions that suppress the auxotrophy of serovar Dublin. The auxotrophy of serovar Dublin was tested under the following conditions: (i) aerobic with various carbon sources (acetate, ethanolamine, glucose, glycerol, propanediol, propionate, or ribose); (ii) anaerobic with one of the above carbon sources and nitrate or tetrathionate as electron acceptor; and (iii) aerobic and anaerobic with glucose plus aspartate (a precursor of pyridines), plus thiamine (required with pyridines by some low-level streptomycin resistant [strB] mutants), plus NaCl (crystals and concentrations up to 1 mM), which corrects many missense mutations (19), plus iron (40 µM FeSO4) since oxidative stress stimulates the pyridine nucleotide cycle (31), or plus Casamino Acids, shown to correct some leaky nad mutants (16, 18, 41).

Slight correction was provided anaerobically by Casamino Acids, but not by any of the other conditions tested. Casamino Acids did not correct nadA, nadB, or nadC insertion (null) mutants of either serovar Dublin or serovar Typhimurium, eliminating contamination by pyridines. We suggest that the serovar Dublin defect is slightly leaky and growth is improved by reducing the demand for NAD (NADP). Provided amino acids may spare the need for NADP in biosynthesis and glucose, by allowing fermentation, may spare the need for NAD in respiration.

Pyridine limitation does not provide antibiotic resistance in serovar Dublin. Streptomycin resistance was tested on minimal medium with growth-limiting levels of nicotinic acid (10–6 M, 3 x 10–7 M, 10–7 M, and 3 x 10–8 M). Pyridine limitation of Nad serovar Dublin strains did not increase Strr above that seen for Nad+ isolates (or recombinants) or for Nad strains with excess pyridine.

Frequency of Nad auxotrophs in natural isolates of S. enterica and E. coli. Auxotrophy is more common among clinical isolates than among isolates from healthy individuals or environmental sites (36). To test a wider range of isolates, S. enterica and E. coli strains from three collections were tested—SARB (6), SARA (4), and ECOR (30).

The SARB collection includes three serovar Dublin isolates, two of which are NAD auxotrophs. SARB12 requires Na, SARB13 requires Na plus thiamine, but SARB14 is prototrophic. The only other Na auxotrophs in the SARB and SARA collections were SARB4 and -6, both of serovar Choleraesuis. Of the 72 ECOR strains of E. coli, only ECOR23 and ECOR29 required nicotinate.

Natural auxotrophy is not associated with mutators or hot spots. In addition to pyridine auxotrophs, the ECOR collection contained one strain (ECOR47) that required proline and another (ECOR49) that required cysteine. In the SARA collection, SARA6 and -28 required purine and SARA33 required cysteine. Surprisingly, 23 of 72 strains in the SARB collection (32%) required one or more growth factors; the most common was purine (nine isolates).

The high auxotroph frequency among SARB strains does not reflect mutators. None of the SARB auxotrophs exhibited a high rate of mutation to rifampin resistance (Rifr). Only one SARB strain (nonauxotrophic strain 38) acquired Rifr at a rate suggestive of a mutator allele. The nadA mutation found in serovar Dublin strains is not at a cytosine methylation site, which can cause a local mutation hot spot (8).

Summary. Evidence is provided that independent serovar Dublin isolates owe their auxotrophy to a single nadA missense mutation. None of the tests supported suppression, positive selection, or high mutation rate as explanations for persistence of this allele. The low level of pyridine required (<1 µM nicotinamide) is likely to be found in host organisms but may not be present in soil or water. Thus selection for pyridine synthesis may be weak in bacteria that transfer directly from one host to another without considerable time in soil or water. This might apply to serovar Dublin and pathogenic strains of E. coli and is consistent with higher auxotroph frequencies among clinical isolates (20, 36). The fact that serovar Dublin has not accumulated additional nad mutations suggests that mutation rates are low and/or the mutation observed is of recent origin. Consistent with weak selection, sequence data suggested repeated loss and recombinational repair of the nadA locus. The nadA gene may be mutationally lost during extended periods of relaxed selection and reacquired by horizontal transfer when selection is reimposed (22). Missense mutations like that described here cannot be detected by genome comparisons alone and may be common in natural isolates.


    ACKNOWLEDGMENTS
 
This work was supported in part by NIH grant GM23408.

We thank Julianne Grose for helpful suggestions throughout the course of this work.


    FOOTNOTES
 
* Corresponding author. Present address: Microbiology Section of the Division of Biological Sciences, Center for Genetics and Development, University of California, Davis, Davis, CA 95616-8665. Phone: (530) 752-6679. Fax: (530) 752-7663. E-mail: jrroth{at}ucdavis.edu. Back

{dagger} Present address: Department of Biology, Indiana University, Bloomington, IN 47405. Back


    REFERENCES
 Top
 Abstract
 Text
 References
 

  1. Achtman, M., A. Mercer, B. Kusecek, A. Pohl, M. Heuzenroeder, W. Aaronson, A. Sutton, and R. P. Silver. 1983. Six widespread bacterial clones among Escherichia coli K1 isolates. Infect. Immun. 39:315-335.[Abstract/Free Full Text]
  2. Bayliss, C. D., D. Field, and E. R. Moxon. 2001. The simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis. J. Clin. Investig. 107:657-662.[Medline]
  3. Bayne, H. G., and E. Thal. 1962. The growth factor requirements of Salmonella dublin. Acta Vet. Scand. 3:119-125.
  4. Beltran, P., S. A. Plock, N. H. Smith, T. S. Whittam, D. C. Old, and R. K. Selander. 1991. Reference collection of strains of the Salmonella typhimurium complex from natural populations. J. Gen. Microbiol. 137:3.
  5. Blattner, F. R., G. Plunkett III, C. A. Bloch, N. T. Perna, V. Burland, M. Riley, J. Collado-Vides, J. D. Glasner, C. K. Rode, G. F. Mayhew, J. Gregor, N. W. Davis, H. A. Kirkpatrick, M. A. Goeden, D. J. Rose, B. Mau, and Y. Shao. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1474.[Abstract/Free Full Text]
  6. Boyd, E. F., F. S. Wang, P. Beltran, S. A. Plock, K. Nelson, and R. K. Selander. 1993. Salmonella reference collection B (SARB): strains of 37 serovars of subspecies I. J. Gen. Microbiol. 139:1125-1132.
  7. Bulgin, M. S. 1983. Salmonella dublin: what veterinarians should know. J. Am. Vet. Med. Assoc. 182:116-118.[Medline]
  8. Coulondre, C., J. H. Miller, P. J. Farabaugh, and W. Gilbert. 1978. Molecular basis of base substitution hotspots in Escherichia coli. Nature 274:775-780.[CrossRef][Medline]
  9. Deng, W., S. R. Liou, G. Plunkett III, G. F. Mayhew, D. J. Rose, V. Burland, V. Kodoyianni, D. C. Schwartz, and F. R. Blattner. 2003. Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18. J. Bacteriol. 185:2330-2337.[Abstract/Free Full Text]
  10. Fang, F. C., and J. Fierer. 1991. Human infection with Salmonella dublin. Medicine (Baltimore) 70:198-207.[Medline]
  11. Fierer, J., and W. Fleming. 1983. Distinctive biochemical features of Salmonella dublin isolated in California. J. Clin. Microbiol. 17:552-554.[Abstract/Free Full Text]
  12. Flachmann, R., N. Kunz, J. Seifert, M. Gutlich, F. J. Wientjes, A. Laufer, and H. G. Gassen. 1988. Molecular biology of pyridine nucleotide biosynthesis in Escherichia coli. Cloning and characterization of quinolinate synthesis genes nadA and nadB. Eur. J. Biochem. 175:221-228.
  13. Foster, J. W., Y. K. Park, T. Penfound, T. Fenger, and M. P. Spector. 1990. Regulation of NAD metabolism in Salmonella typhimurium: molecular sequence analysis of the bifunctional nadR regulator and the nadA-pnuC operon. J. Bacteriol. 172:4187-4196.[Abstract/Free Full Text]
  14. Funchain, P., A. Yeung, J. L. Stewart, R. Lin, M. M. Slupska, and J. H. Miller. 2000. The consequences of growth of a mutator strain of Escherichia coli as measured by loss of function among multiple gene targets and loss of fitness. Genetics 154:959-970.[Abstract/Free Full Text]
  15. Hudson, R. E., U. Bergthorsson, J. R. Roth, and H. Ochman. 2002. Effect of chromosome location on bacterial mutation rates. Mol. Biol. Evol. 19:85-92.[Abstract/Free Full Text]
  16. Hughes, K. T., D. Ladika, J. R. Roth, and B. M. Olivera. 1983. An indispensable gene for NAD biosynthesis in Salmonella typhimurium. J. Bacteriol. 155:213-221.[Abstract/Free Full Text]
  17. Jin, Q., Z. Yuan, J. Xu, Y. Wang, Y. Shen, W. Lu, J. Wang, H. Liu, J. Yang, F. Yang, X. Zhang, J. Zhang, G. Yang, H. Wu, D. Qu, J. Dong, L. Sun, Y. Xue, A. Zhao, Y. Gao, J. Zhu, B. Kan, K. Ding, S. Chen, H. Cheng, Z. Yao, B. He, R. Chen, D. Ma, B. Qiang, Y. Wen, Y. Hou, and J. Yu. 2002. Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 30:4432-4441.[Abstract/Free Full Text]
  18. Kerr, T. J., M. W. Williams, J. J. Rowe, G. J. Tritz, and C. J. Washam. 1983. Detection and characterization of a nicotinic acid-replacing substance in vitamin-free acid hydrolyzed casein. J. Dairy Sci. 66:743-749.[Abstract/Free Full Text]
  19. Kohno, T., and J. R. Roth. 1979. Electrolyte effects on the activity of mutant enzymes in vivo and in vitro. Biochemistry 18:1386-1392.[CrossRef][Medline]
  20. Kunin, C. M., T. H. Hua, C. Krishnan, L. Van Arsdale White, and J. Hacker. 1993. Isolation of a nicotinamide-requiring clone of Escherichia coli O18:K1:H7 from women with acute cystitis: resemblance to strains found in neonatal meningitis. Clin. Infect. Dis. 16:412-416.[Medline]
  21. Kunin, C. M., H. H. Tong, and W. E. Maher. 1993. Naturally-occurring, osmo-remedial variants of Escherichia coli. J. Med. Microbiol. 38:216-221.[Abstract]
  22. Lawrence, J. G., and J. R. Roth. 1999. Genomic flux: genome evolution by gene loss and acquisition, p. 263-289. In R. Charlebois (ed.), Analysis of small genomes. ASM Press, Washington, D.C.
  23. LeClerc, J. E., B. Li, W. L. Payne, and T. A. Cebula. 1996. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274:1208-1211.[Abstract/Free Full Text]
  24. Libby, S. J., L. G. Adams, T. A. Ficht, C. Allen, H. A. Whitford, N. A. Buchmeier, S. Bossie, and D. G. Guiney. 1997. The spv genes on the Salmonella dublin virulence plasmid are required for severe enteritis and systemic infection in the natural host. Infect. Immun. 65:1786-1792.[Abstract]
  25. Luria, S. E., and M. Delbrück. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491-511.[Free Full Text]
  26. Mantis, N. J., and P. J. Sansonetti. 1996. The nadB gene of Salmonella typhimurium complements the nicotinic acid auxotrophy of Shigella flexneri. Mol. Gen. Genet. 252:626-629.[Medline]
  27. Martin, P., T. van de Ven, N. Mouchel, A. C. Jeffries, D. W. Hood, and E. R. Moxon. 2003. Experimentally revised repertoire of putative contingency loci in Neisseria meningitidis strain MC58: evidence for a novel mechanism of phase variation. Mol. Microbiol. 50:245-257.[CrossRef][Medline]
  28. McClelland, M., K. E. Sanderson, J. Spieth, S. W. Clifton, P. Latreille, L. Courtney, S. Porwollik, J. Ali, M. Dante, F. Du, S. Hou, D. Layman, S. Leonard, C. Nguyen, K. Scott, A. Holmes, N. Grewal, E. Mulvaney, E. Ryan, H. Sun, L. Florea, W. Miller, T. Stoneking, M. Nhan, R. Waterston, and R. K. Wilson. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852-856.[CrossRef][Medline]
  29. Nimmich, W., and G. Zingler. 1984. Biochemical characteristics, phage patterns, and O1 factor analysis of Escherichia coli O1:K1:H7:F11 and O1:K1:H-:F9 strains isolated from patients with urinary tract infections. Med. Microbiol. Immunol. 173:75-85.[CrossRef][Medline]
  30. Ochman, H., and R. K. Selander. 1984. Standard reference strains of Escherichia coli from natural populations. J. Bacteriol. 157:690-693.[Abstract/Free Full Text]
  31. Park, U. E., B. M. Olivera, K. T. Hughes, J. R. Roth, and D. R. Hillyard. 1989. DNA ligase and the pyridine nucleotide cycle in Salmonella typhimurium. J. Bacteriol. 171:2173-2180.[Abstract/Free Full Text]
  32. Parkhill, J., G. Dougan, K. D. James, N. R. Thomson, D. Pickard, J. Wain, C. Churcher, K. L. Mungall, S. D. Bentley, M. T. Holden, M. Sebaihia, S. Baker, D. Basham, K. Brooks, T. Chillingworth, P. Connerton, A. Cronin, P. Davis, R. M. Davies, L. Dowd, N. White, J. Farrar, T. Feltwell, N. Hamlin, A. Haque, T. T. Hien, S. Holroyd, K. Jagels, A. Krogh, T. S. Larsen, S. Leather, S. Moule, P. O'Gaora, C. Parry, M. Quail, K. Rutherford, M. Simmonds, J. Skelton, K. Stevens, S. Whitehead, and B. G. Barrell. 2001. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413:848-852.[CrossRef][Medline]
  33. Penfound, T., and J. W. Foster. 1996. Biosynthesis and recycling of NAD, p. 721-730. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella typhimurium. Molecular and cellular biology, vol. 2. ASM Press, Washington, D.C.
  34. Perna, N. T., G. Plunkett III, V. Burland, B. Mau, J. D. Glasner, D. J. Rose, G. F. Mayhew, P. S. Evans, J. Gregor, H. A. Kirkpatrick, G. Posfai, J. Hackett, S. Klink, A. Boutin, Y. Shao, L. Miller, E. J. Grotbeck, N. W. Davis, A. Lim, E. T. Dimalanta, K. D. Potamousis, J. Apodaca, T. S. Anantharaman, J. Lin, G. Yen, D. C. Schwartz, R. A. Welch, and F. R. Blattner. 2001. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409:529-533.[CrossRef][Medline]
  35. Pupo, G. M., R. Lan, and P. R. Reeves. 2000. Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics. Proc. Natl. Acad. Sci. USA 97:10567-10572.[Abstract/Free Full Text]
  36. Robeson, J. P., R. M. Goldschmidt, and R. Curtiss III. 1980. Potential of Escherichia coli isolated from nature to propagate cloning vectors. Nature 283:104-106.[CrossRef][Medline]
  37. Sasarman, A., K. E. Sanderson, M. Surdeanu, and S. Sonea. 1970. Hemin-deficient mutants of Salmonella typhimurium. J. Bacteriol. 102:531-536.[Abstract/Free Full Text]
  38. Schlessinger, D. 1988. Failure of aminoglycoside antibiotics to kill anaerobic, low-pH, and resistant cultures. Clin. Microbiol. Rev. 1:54-59.[Abstract/Free Full Text]
  39. Selander, R. K., N. H. Smith, J. Li, P. Beltran, K. E. Ferris, D. J. Kopecko, and F. A. Rubin. 1992. Molecular evolutionary genetics of the cattle-adapted serovar Salmonella dublin. J. Bacteriol. 174:3587-3592.[Abstract/Free Full Text]
  40. Skovran, E., and D. M. Downs. 2000. Metabolic defects caused by mutations in the isc gene cluster in Salmonella enterica serovar Typhimurium: implications for thiamine synthesis. J. Bacteriol. 182:3896-3903.[Abstract/Free Full Text]
  41. Stancek, M., L. A. Isaksson, and M. Ryden-Aulin. 2003. fusB is an allele of nadD, encoding nicotinate mononucleotide adenylyltransferase in Escherichia coli. Microbiology 149:2427-2433.[Abstract/Free Full Text]
  42. Stokes, J. L., and H. G. Bayne. 1958. Growth-factor-dependent strains of salmonellae. J. Bacteriol. 76:417-421.[Free Full Text]
  43. Watanabe, H., and N. Okamura. 1992. The genus Shigella, p. 2754-2759. In H. Balows, H. G. Truper, M. Dworkin, W. Harder, and K. H. Schleifer (ed.), The prokaryotes. Springer-Verlag, New York, N.Y.
  44. Wei, J., M. B. Goldberg, V. Burland, M. M. Venkatesan, W. Deng, G. Fournier, G. F. Mayhew, G. Plunkett III, D. J. Rose, A. Darling, B. Mau, N. T. Perna, S. M. Payne, L. J. Runyen-Janecky, S. Zhou, D. C. Schwartz, and F. R. Blattner. 2003. Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect. Immun. 71:2775-2786.[Abstract/Free Full Text]
  45. Welch, R. A., V. Burland, G. Plunkett III, P. Redford, P. Roesch, D. Rasko, E. L. Buckles, S. R. Liou, A. Boutin, J. Hackett, D. Stroud, G. F. Mayhew, D. J. Rose, S. Zhou, D. C. Schwartz, N. T. Perna, H. L. Mobley, M. S. Donnenberg, and F. R. Blattner. 2002. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. USA 99:17020-17024.[Abstract/Free Full Text]
  46. Welch, W. D., L. Spurgeon, D. Kitts, H. S. Moyed, and L. D. Thrupp. 1981. Unique temperature-sensitive nutritional requirements of bacteremic Escherichia coli isolates. J. Clin. Microbiol. 13:606-608.[Abstract/Free Full Text]


Journal of Bacteriology, January 2005, p. 400-403, Vol. 187, No. 1
0021-9193/05/$08.00+0     doi:10.1128/JB.187.1.400-403.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergthorsson, U.
Right arrow Articles by Roth, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergthorsson, U.
Right arrow Articles by Roth, J. R.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Appl. Environ. Microbiol. Infect. Immun. Eukaryot. Cell
Mol. Cell. Biol. J. Virol. Microbiol. Mol. Biol. Rev.
ALL ASM JOURNALS